TY - JOUR
T1 - Noninfectious granulomatous dermatitides
T2 - A review of 8 disorders (Part 2 of 3)
AU - Goldminz, Ari M.
AU - Gottlieb, Alice B.
N1 - Publisher Copyright:
© 2013 Frontline Medical Communications.
PY - 2013/9/1
Y1 - 2013/9/1
N2 - In this review we focus on 3 of the non-infectious granulomatous dermatitides, annular elastolytic giant cell granuloma, necrobiosis lipoidica, and necrobiosis xanthogranuloma, with an overview of their clinical and histological presentations, differential diagnoses, and treatment options. The disorders we discuss are polymorphic in their clinical and histopathological presentations, follow chronic or undulating disease courses, and are typically recalcitrant to therapeutic interventions. Although the clinical history may be helpful, careful and thorough histopathological examination is required. Established treatment algorithms for these disorders are lacking, and very few randomized, placebo-controlled studies have been published. Future investigations should focus on the evaluation of larger cohorts, not only to establish treatment recommendations in randomized, placebo-controlled trials, but also to reach a greater understanding of disease pathogenesis and clinical-pathological presentation.
AB - In this review we focus on 3 of the non-infectious granulomatous dermatitides, annular elastolytic giant cell granuloma, necrobiosis lipoidica, and necrobiosis xanthogranuloma, with an overview of their clinical and histological presentations, differential diagnoses, and treatment options. The disorders we discuss are polymorphic in their clinical and histopathological presentations, follow chronic or undulating disease courses, and are typically recalcitrant to therapeutic interventions. Although the clinical history may be helpful, careful and thorough histopathological examination is required. Established treatment algorithms for these disorders are lacking, and very few randomized, placebo-controlled studies have been published. Future investigations should focus on the evaluation of larger cohorts, not only to establish treatment recommendations in randomized, placebo-controlled trials, but also to reach a greater understanding of disease pathogenesis and clinical-pathological presentation.
KW - Aminolevulinic acid
KW - Annular elastolytic giant cell granuloma
KW - Diabetes mellitus
KW - Necrobiosis lipoidica diabeticorum
KW - Necrobiosis xanthogranuloma
KW - Tumor necrosis factor
UR - http://www.scopus.com/inward/record.url?scp=85022346801&partnerID=8YFLogxK
U2 - 10.12788/j.sder.0035
DO - 10.12788/j.sder.0035
M3 - Review article
AN - SCOPUS:85022346801
SN - 1085-5629
VL - 32
SP - e1-e6
JO - Seminars in Cutaneous Medicine and Surgery
JF - Seminars in Cutaneous Medicine and Surgery
IS - 3
ER -